https://orcid.org/0000-0002-7905-4284
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xiaoniu Miao, Yi Luo, Xi Huang, Suki M. Y. Lee, Zhijun Yuan, Yongzhou Tang, Liandi Chen, Chao Wang, Fan Wu, Yifeng Xu, Wenchao Jiang, Wei Gao, Xuedong Song, Yao Yan, Tuling Pang, Cheng Chen, Yuefeng Zou, Weihui Fu, Liping Wan, Javier Gilbert-Jaramillo, Michael Knight, Tiong Kit Tan, Pramila Rijal, Alain Townsend, Joanne Sun, Xiaolin Liu, William James, Andy Tsun & Yingda Xu. (2020) A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy. mAbs 12:1.
Read now
Read now
Articles from other publishers (4)
Fanlin Li, Wei Xu, Xiaoqing Zhang, Wanting Wang, Shan Su, Ping Han, Haiyong Wang, Yanqin Xu, Min Li, Lilv Fan, Huihui Zhang, Qiang Dai, Hao Lin, Xinyue Qi, Jie Liang, Xin Wang, Shibo Jiang, Youhua Xie, Lu Lu & Xuanming Yang. (2023) A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo. Communications Biology 6:1.
Crossref
Crossref
Anca Pantea StoianPeter KemplerThomas StulnigAli A. Rizvi & Manfredi Rizzo. (2022) Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us. Metabolic Syndrome and Related Disorders 20:3, pages 137-140.
Crossref
Crossref
Takuya Tada, Chen Fan, Jennifer S. Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry Gristick, Belinda M. Dcosta, Craig B. Wilen, Crina M. Nimigean & Nathaniel R. Landau. (2020) An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2. Cell Reports 33:12, pages 108528.
Crossref
Crossref
Daniel Tusé, Somen Nandi, Karen A. McDonald & Johannes Felix Buyel. (2020) The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be. Frontiers in Plant Science 11.
Crossref
Crossref